GENE ONLINE|News &
Opinion
Blog

Immunotherapy
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
FDA Drops New Oncology Development Guidelines
2022-10-18
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Europe Okays Roche’s CAR-T Competitor for Blood Cancer
2022-06-09
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
Kite’s Yescarta – The First CAR-T Cell Therapy Approved for B cell Lymphoma
2022-04-06
1 2 3 7
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top